Shire sells oncology unit to France ’s Servier for $2.4bn
Shire has struck a deal to sell its oncology business for $2.4bn in cash to a French pharmaceutical group, complicating the position for Japan ’s Takeda Pharmaceutical which said last month that it was considering a bid for the Irish drugmaker.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Cat Rutter Pooley Source Type: news
More News: Biotechnology | Cancer & Oncology | France Health | Health Management | Ireland Health | Japan Health